These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11346077)

  • 21. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
    Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
    Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inmates in Irish prisons face drug abuse and disease.
    Birchard K
    Lancet; 1999 Aug; 354(9180):753. PubMed ID: 10475200
    [No Abstract]   [Full Text] [Related]  

  • 24. [Co-infection of hepatitis C and HIV].
    Rodríguez Martínez A
    Aten Primaria; 2003 May; 31(9):617. PubMed ID: 12783757
    [No Abstract]   [Full Text] [Related]  

  • 25. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Crofts N; Aitken CK; Kaldor JM
    Med J Aust; 1999 Mar; 170(5):220-1. PubMed ID: 10092920
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
    Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
    J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structured information exchange on infectious diseases for prisoners.
    Flühmann P; Wassmer M; Schwendimann R
    J Correct Health Care; 2012 Jul; 18(3):198-209. PubMed ID: 22569902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
    Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
    Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incarceration and infection: drug policy in the USA.
    Burki T
    Lancet Infect Dis; 2017 Jul; 17(7):697. PubMed ID: 28737490
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C: waiting for the grim reaper.
    Wodak A
    Med J Aust; 1997 Mar; 166(6):284-5. PubMed ID: 9087180
    [No Abstract]   [Full Text] [Related]  

  • 35. Prisons, hepatitis C and harm minimisation.
    Levy MH; Treloar C; McDonald RM; Booker N
    Med J Aust; 2007 Jun; 186(12):647-9. PubMed ID: 17576183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scale-up of hepatitis C treatment in prisons is key to national elimination.
    Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
    Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
    [No Abstract]   [Full Text] [Related]  

  • 37. Study size and documentation to detect injection-related hepatitis C in prison.
    Gore SM; Bird AG
    QJM; 1998 May; 91(5):353-7. PubMed ID: 9709469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of HIV transmission in an Australian prison.
    Dolan K; Hall W; Wodak A; Gaughwin M
    Med J Aust; 1994 Jun; 160(11):734. PubMed ID: 8202021
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing hepatitis C virus transmission in Australians who inject drugs.
    Watson KJ
    Med J Aust; 2000 Jan; 172(2):55-6. PubMed ID: 10738472
    [No Abstract]   [Full Text] [Related]  

  • 40. Surveillance and prevention of hepatitis C in Australian prisons.
    Dolan K
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.